Transposable elements (TEs) have been of paramount importance in shaping genomic and epigenomic landscapes of their hosts and in driving the expansion of gene regulatory networks during mammalian evolution. They are found in nearly all long non-coding RNAs (lncRNAs) and have promoted their evolution and function, often in a species-and tissuespecific manner. X-chromosome inactivation (XCI) is an essential process that relies on several TE-enriched lncRNAs. While XCI is conserved across species, one striking difference between human and mouse is the existence of XACT (X active coating transcript), a human-specific lncRNA that coats active X chromosomes in pluripotent cells and may oppose X chromosome silencing in this context. Here, we explore how different families of TEs have contributed to shaping the XACT locus and how they couple its expression to pluripotency in humans. Through a combination of sequence analysis across primates, transcriptional interference and genome editing in human embryonic stem cells (hESCs), we identify a critical enhancer for the transcriptional regulation of the XACT locus that evolved from an ancestral group (LTR48B/ERV1) of mammalian endogenous retroviruses (ERVs), prior to the emergence of XACT. Furthermore, we show that this ancient ERV was hijacked by evolutionarily younger hominoid-specific ERVs that gave rise to the promoter of XACT, thus wiring its expression to the pluripotency network.
Introduction
More than half of the human genome is composed of transposable elements (TEs), which are mobile genomic DNA elements capable of autonomous and non-autonomous replication 1, 2 . The vast majority of human TEs are retrotransposons, which can be divided into three classes: long interspersed elements (LINEs), short interspersed elements (SINEs) and endogenous retroviruses (ERVs). Classically seen as junk and parasitic DNA, the last decades have brought TEs into the limelight as important drivers of genome evolution [3] [4] [5] [6] . TEs have been a major force for the evolution of genomes, promoting structural variation, genome size expansion, tridimensional organization, genetic diversity as well as affecting gene regulation 4, [7] [8] [9] . Their recognized role as a source of regulatory innovation stems from the co-option of TEs by their hosts, either creating or modifying genes (both coding and non-coding) or by acting as regulatory elements [10] [11] [12] . Indeed, TEderived regulatory elements, such as the long terminal repeats (LTRs) flanking ERVs, are abundantly distributed across the human genome and have the ability to rewire genes into coordinated networks of transcriptional regulation. For example, certain classes of ERVs, such as HERVK and HERVH, have been shown to influence the expression of genes in pluripotent contexts [13] [14] [15] [16] [17] . This occurs through the emergence of novel genes containing the promoter sequence of the ERVs or by rewiring the expression of existing genes located in the vicinity of an ERV-derived enhancer. In both cases, the ERVs provide transcription factor binding platforms for master regulators of pluripotency, such as OCT4, SOX2 and NANOG that wire the expression of these genes to pluripotency. However, the uncontrolled transposition of TEs in the genome can potentially have detrimental effects for its host. Thus, several mechanisms exist that keep TEs in check to prevent deleterious changes in the host genome 18 . The delicate balance resulting from this skirmish between the host and TEs has to ensure that essential biological processes are conserved while, at the same time, allowing the emergence of novel regulatory mechanisms. For this reason, the presence of TEs in exonic sequences of protein coding genes is rather low, likely as a result of counterselection. In contrast, TEs are overrepresented in vertebrate long non-coding RNAs (lncRNAs), with almost all of them containing at least one TE in their sequence [19] [20] [21] . This "alliance" between TEs and lncRNAs constitutes an intricate and rich strategy to control biological processes that are tightly linked to the developmental state. A paradigm of such a process is X-chromosome inactivation (XCI). In females of all mammalian species, XCI achieves transcriptional shutdown of one X chromosome, by converting it into facultative heterochromatin. XCI takes place during early development and is generally established at the exit of pluripotency 22 . Its initiation is under the control of a region on the X chromosome called the X-inactivation center (XIC), and chromosome silencing is triggered by the accumulation of a lncRNA produced from the XIC, XIST 23, 24 . Besides XIST, several other lncRNA genes are found within the XIC and have been shown to play diverse roles in the regulation of XCI 25 . Interestingly, all of the lncRNAs found within this region have evolved from the pseudogenization of protein-coding genes driven by the integration of different TEs 26 .
In human, XIST starts being expressed from the 8-cell stage, concomitantly with zygotic genome activation, and from all X chromosomes, including in males [27] [28] [29] . However, XCI only occurs several days after the initial accumulation of XIST 30, 31 and thus, is transiently disconnected from the expression of XIST. This raises the question as to how X chromosomes are mechanistically protected from being silenced in the initial stages when XIST starts being expressed and how is XCI coupled to a later developmental stage in humans. We have previously identified XACT, a repeat-rich lncRNA, which has the striking property of coating active X chromosomes in early human embryonic stages 32 . Studies in human embryonic stem cells (hESCs) and human embryos suggest that XACT can affect XIST expression, localization or activity in these contexts 31, 33 . Thus, XACT could act as a transient XIST antagonist, ensuring that XCI is established at the right developmental stage. Understanding how this lncRNA evolved in humans and the mechanisms linking its expression to pluripotent contexts is thus, of the uttermost importance.
In this study, we explore the contribution of distinct classes of ERVs in the molecular coupling of XACT expression to pluripotency. Through an analysis of the XACT surrounding region across primates and using a combination of transcriptional interference and genome editing approaches in hESCs, we identify a critical genomic element required for XACT expression. We show that this element, which acts as an enhancer, belongs to a family of ERVs found across mammalian species. Our findings suggest an exaptation of an ancient ERV by younger hominoid-specific ERVs that gave rise to XACT and illustrate how retroviral-derived sequences may intervene in speciesspecific regulatory pathways.
Results

The emergence of the XACT and T113.3 genes was driven by hominoid-specific ERV elements
In order to explore the emergence and regulation of XACT, we revisited the organization and evolution of this locus. The XACT gene is located in a large intergenic region on the X chromosome, between the protein coding-genes AMOT and HTR2C 32 . Another gene of unknown function, T113.3, is found approximately 50 kb upstream of XACT. We analyzed the organization of this region in humans in comparison with five other primate species (chimpanzee, gorilla, gibbon, rhesus macaque and marmoset) and observed an overall conservation of the syntenic region extending from the LHFPL1 to the LRCH2 genes (upstream of AMOT and downstream of HTR2C, respectively) ( Fig. 1A) . All protein coding genes (LHFPL1, AMOT, HTR2C and LRCH2) display the same genomic organization, orientation and high exon sequence identity throughout all primate species. In contrast, XACT and T113.3 show a limited sequence identity across primates, particularly in species more distantly related to humans ( Fig. 1A) . Notably, the sequences corresponding to the promoter region of XACT and T113.3 are conserved in hominoids, but not in rhesus macaque or more distant primate species (Fig. 1B ). This suggests that the emergence of these two genes is a recent evolutionary event that occurred concomitantly in the genome of the last common ancestor of macaque and gibbons some 20 Myr ago (Fig. 1C ).
In hESCs, XACT is expressed from the minus strand, whereas T113.3 is expressed from the opposite strand ( Fig. 1D ). In this cellular context, the transcription start sites (TSS) of XACT and T113.3 are enriched in H3 Lys4 trimethylation (H3K4me3), suggesting these are the bona fide promoters of their respective genes ( Fig. 1D ). In induced pluripotent stem cells (iPSCs) from chimpanzee, XACT is similarly expressed, but not T113.3, despite its sequence conservation. As expected, no expression is detected from these loci in macaque, due to the lack of the promoters for both XACT and T113.3 (Sup. Fig. 1 ) 34 .
Analysis of the repeat composition of XACT and T113.3 promoters revealed that both were shaped by the insertion of several LTR/HERV elements. The region surrounding the promoter of XACT is composed of fragments of LTRs belonging to different groups: LTR5_HS, MER83B, MLT2A1 and LTR49. Rapid amplification of cDNA ends (RACE) has previously shown that the MLT2A1 element corresponds to the TSS of XACT 32 . The T113.3 gene derives from the insertion of a 5.1 kb fragment of a HERVH element, including its 5' LTR7 promoter, which acts as the TSS for T113. 3 . In addition, other parts of the GAG and POL coding regions as well as other HERVs, such as MER21C and MER4B, constitute the remaining of the gene (Fig. 1D ). Altogether, this indicates that XACT and T113.3 share a similar evolutionary history, which is mostly dependent on the introduction of hominoid-specific ERVs in the XACT/T113.3 loci.
The expression dynamics of XACT and T113.3 are correlated during early embryogenesis and differentiation of hESCs
To understand whether the transcription of XACT and T113.3 is controlled by a shared regulatory network, we first explored the patterns and dynamics of their expression in hESCs and upon their differentiation. We observed, using RNA-FISH, that XACT and T113.3 are co-expressed from the active X chromosome (Xa) in both male (H1) and female (H9) hESCs before differentiation, with a minority of cells expressing either transcript individually ( Fig. 2A , Sup. Fig. 2A ). Their expression dynamics is also strongly correlated across a 10-day differentiation time course of male and female hESCs ( Fig. 2B , Sup. Fig. 2B ), with both genes being turned off from day 3 onwards.
We further explored the transcriptional dynamics of XACT and T113.3 in human preimplantation embryos using public single-cell RNA sequencing datasets 30, [35] [36] [37] .
Expression from both loci can be detected concomitantly between the four-and the eightcell stages, likely following the major wave of zygotic gene activation (Sup. Fig. 2C ).
Furthermore, the expression detected from the XACT and T113.3 loci is correlated at early (E3 to early E5) and late (E5 to E7) stages of development in both female and male embryos ( Fig. 2C) . A weaker transcriptional correlation between XIST and T113.3 is observed in early stages of pre-implantation development, but is mostly lost at later stages (Sup. Fig. 2D ). These observations confirm that the XACT and T113.3 loci display similar transcriptional dynamics in different pluripotent contexts, in hESCs and in early embryos, suggesting that they may be co-regulated.
To corroborate this hypothesis, we analyzed Hi-C datasets 38 from H1 hESCs and from human foreskin fibroblasts (HFF), in which XACT and T113.3 are expressed and silenced, respectively. In hESCs, the 5' region of XACT is embedded within a local compartment that includes T113.3 and expands into the upstream LRCH2 gene, while in fibroblasts this local compartmentalization is absent (Fig. 2D ). This indicates that the regulatory sequences of XACT and T113.3 belong to the same TAD in cells where both genes are expressed.
Interfering with T113.3 transcription impairs XACT expression
To test whether the expression of XACT or of T113.3 are interdependent, we performed CRISPR interference (CRISPRi), using a catalytically dead Cas9 coupled with a repressive KRAB domain (dCas9-KRAB) to induce local heterochromatinization of the TSS regions of XACT and T113.3 39 . Given the similarity of XACT/T113.3 expression dynamics in female and male pluripotent contexts, we performed all our functional assays in male H1 hESCs. We first generated H1 hESCs stably expressing the CRISPRi machinery together with gRNAs targeting the promoter of either XACT or T113.3 ( CRISPRi spreads only locally, up to 6 kb away from the targeted site, but does not reach the XACT promoter ( Fig. 3B ), while the distribution of H3K4me3 and H3K27ac changes only slightly across the loci, likely reflecting the transcriptional changes induced by the CRISPRi machinery (Sup. Fig. 3B ). Altogether, this suggests that the T113.3 locus participates in the regulation of XACT expression, either through the T113.3 transcript, the act of transcription or the chromatin landscape around the LTR7 forming the T113.3 promoter.
T113.3 promoter and transcripts are dispensable for XACT expression
The LTR7/HERVH class of retrotransposons has been linked to the transcriptional control of human pluripotency 15, 17 . We thus hypothesized that the LTR7/HERVH defining the We next tested the role of the T113.3 LTR7/HERVH in the regulation of XACT, by using CRISPR/Cas9 to delete a 25 kb region encompassing the entire T113.3 gene (including the whole LTR7/HERVH element at its 5' end) in H1 hESCs (Sup. Fig. 4B ). We screened individual colonies by PCR for the presence of a deletion or an inversion of the T113.3 gene and selected three independent clones of each genotype (WT, deleted and inverted, Sup. Fig. 4B ) for further analysis. All clones, independently of their genotype, showed comparable expression levels of X-linked (AMOT, HTR2C, ATRX), pluripotency (OCT4) and differentiation marker genes (NODAL) (Sup. Fig. 4C ). As expected, T113.3 RNA could not be detected in clones carrying a deletion of the locus; in addition, the inversion of the T113.3 gene lead to the complete abrogation of T113.3 transcription ( Fig. 4B ). However, none of these mutations affected the expression levels of XACT in hESCs ( Fig. 4B ). In addition, the expression dynamics of XACT during undirected differentiation of the T113.3 mutant hESCs ( Fig. 4C ) and the global kinetics of the differentiation were unaffected (Sup. Fig. 4D ). These results clearly show that the LTR7/HERVH defining the T113.3 gene is dispensable for the expression of XACT in hESCs and for its silencing dynamics during cellular differentiation.
A genomic element upstream of T113.3 acts as a common enhancer for the
XACT/T113.3 locus and wires it to the pluripotency network
The analysis of H3K27ac distribution across the locus, a mark of active enhancers, pointed to a potential regulatory region approximately 2 kb upstream of the T113.3 TSS (Sup. Fig. 3B ). Examination of ATAC-seq and ChIP-seq datasets from H1 hESCs 40 confirmed the existence of a broad acetylation domain, which is not found in fetal fibroblasts ( Fig. 5A , Sup. Fig. 5A ), suggesting that this region may serve as a pluripotent specific enhancer. Further inspection of ChIP-seq profiles revealed that this domain encompasses a CTCF peak and binding sites for several transcription factors, including pluripotency factors OCT4, SOX2 and NANOG.
In order to test the enhancer activity of this domain and identify which element(s) are involved in the regulation of XACT and T113.3, we used CRISPR/Cas9 to delete either the CTCF or the transcription factor binding (TFB) sites (Sup. Fig. 5B ). We selected at least two independent clones of non-mutated, deleted or inverted genotypes (Sup. Fig.   5B ). All these clones retain normal expression levels of pluripotent markers (NANOG, OCT4), indicating that none of these mutations significantly impact pluripotency (Sup. Fig.   5C ). Deletion or inversion of the CTCF site did not affect steady-state levels of T113.3 or XACT transcripts compared to WT H1 ESCs (Fig. 5B ). In contrast, deletion of the TFB site completely abolished T113.3 transcription and drastically reduced the levels of XACT RNA ( Fig. 5B ). Interestingly, inversion of the TFB site did not perturb the expression of neither XACT nor T113.3, further supporting the role of this genomic element as an enhancer, acting independently of its orientation. Thus, we conclude that a pluripotent specific proximal enhancer, upstream of the T113.3 gene, is essential for the regulation of the XACT/T113.3 loci in hESCs.
To confirm the role of the pluripotency transcription factors OCT4, SOX2 and NANOG in the activity of this enhancer, we used small interfering RNAs (siRNAs) to KD their expression, either individually, or in combination. Western blot analysis revealed that the simultaneous targeting of SOX2 and OCT4 resulted in the depletion of all three master regulators of the pluripotency network ( Fig. 5C ), consistent with the fact that OCT4 positively regulates NANOG 41 . In this condition specifically, we observed a significant reduction of T113.3 and XACT transcript levels ( Fig. 5D , Sup. Fig. 5D ), further supporting the dependence of the locus towards master regulators of the pluripotency circuitry. We excluded an indirect effect linked to KD-induced differentiation, as up-regulation of differentiation markers is observed in all conditions where OCT4 is targeted, while the effect on the XACT/T113.3 loci is seen only when the three factors are simultaneously depleted (Sup. Fig. 5D ). Altogether, this suggests that the enhancer upstream of T113.3 connects the transcriptional regulation of the locus to the pluripotency network in hESCs.
An ancient LTR/HERV enhancer was exapted to wire the XACT/T113.3 locus to the pluripotency network
A closer analysis of the XACT/T113.3 enhancer revealed that it derives from an ancient LTR48B from the ERV1 family ( Fig. 6A ). Unlike XACT and T113.3, which originate from the insertion and exaptation of hominoid-specific LTRs, the LTR48B enhancer is found in all primate species, suggesting that it was introduced in a common ancestor of primates, at least 20 Myr before the LTR/HERV insertions that gave rise to both XACT and T113.3 promoters ( Fig. 6B ). We scanned distinct position weight matrixes (PWM) for core pluripotency transcription factors against the human X-linked LTR48B enhancer element and identified potential binding sites for OCT4, SOX2 and NANOG (Fig. 6C ). These binding sites are conserved in all primate species analyzed here, suggesting that this LTR element evolved as a primate specific enhancer, the activity of which is connected to the pluripotency machinery. To gain further insight into the evolution of the activity of this enhancer in the primate lineage, we explored available iPSC RNA-seq and ChIP-seq datasets from humans and rhesus macaques 42 . As expected, in iPSCs of Rhesus, whose genome lacks the LTR elements defining the promoters of XACT and T113.3, no expression of either gene is observed (Sup. Fig. 6A ). Nonetheless, the LTR48B element coincides with a peak of H3K27ac (Sup. Fig. 6A ), suggesting that this element harbors an active enhancer in Rhesus iPSCs, despite the absence of transcription at the syntenic positions of the XACT and T113.3 genes.
Information about the evolution of the LTR48B family in primates is scarce. We thus investigated whether this family of retroelements may have been co-opted into the pluripotency network of host cells. We scanned the consensus sequence of human LTR48B for the presence of putative binding sites for core pluripotency transcription factors (Sup. Fig. 6B ). Strikingly, the consensus sequence of the LTR48B group lacks potential binding sites for OCT4, SOX2 or NANOG. Accordingly, the majority of LTR48B elements found in the human genome are not bound by OCT4 and NANOG in available ChIP-seq datasets from hESCs 43 (Sup. Fig. 6C, 6D ). Out of the 1026 LTR48B found in the human genome, only thirty-four are bound by NANOG, eight of which are also bound by OCT4 (Sup. Fig. 6E ). This is in contrast with LTR7-HERVH elements, which are bound by OCT4 and NANOG genome-wide (Sup. Fig. 6C , D and E), in agreement with this HERV family being essential for the maintenance of pluripotency in human cells 15, 17 . Collectively, our data shows that an ancient LTR48B element located between XACT and T113.3 has evolved independently of the bulk of the LTR48B family, acquiring binding sites for core pluripotency factors. Recruitment of these factors created an active enhancer in pluripotent cells, which was in turn co-opted by younger LTRs inserted in the locus, giving rise to two novel genes, XACT and T113. 3 .
Discussion
Recent studies have demonstrated the importance of families of TEs in nuclear organization and gene expression regulation [44] [45] [46] . These crucial studies provide general rules about families of TEs and their role, but lack formal demonstration of their regulatory function as well as finer details about the mechanisms used by individual TEs to regulate specific loci in the genome (discussed in 3 ). Indeed, a recent study demonstrating that only a minority of TEs with enhancer features has a role in the regulation of gene expression, calls for a critical assessment of the functional role of individual TEs 47, 48 . Here, we explored the evolutionary history of the XACT locus to decipher the molecular coupling of XACT expression to pluripotency in hESCs. Our study reveals that both XACT and an upstream gene, T113.3, originate from the insertion of elements of various TE classes in the hominoid lineage. In particular, genomic remnants from ancient ERV insertions gave rise to the promoters that drove the emergence of these genes. Moreover, we explore how the expression of these TE-derived genes are wired into the pluripotency transcriptional network. We show that XACT and T113.3 have hijacked an ancestral LTR fragment that acts as an enhancer in pluripotent contexts in all primate species, coupling their expression to early embryogenesis.
It was previously shown that different families of ERVs are dynamically expressed, in a stage-and cell-specific manner, during early development 49 . Importantly, families of hominoid-specific ERVs, such as LTR7/HERVH and LTR5_Hs/HERVK, were shown to rewire different genes into the pluripotent transcriptional network, in part by creating binding platforms for combinations of pluripotency associated transcription factors 17, 46, 50 .
This led us to hypothesize that the T113.3 gene, a highly expressed LTR7/HERVH element located upstream of XACT, could couple its expression to the pluripotent context.
However, we demonstrate that neither the LTR7/HERVH T113.3 gene nor its transcript influence the transcription of XACT in this cellular context. While the importance of the LTR7/HERVH family of retroelements in pluripotency seems undeniable, our work highlights how a careful analysis of specific loci are required to ascertain the regulatory role of individual TEs. Further investigation will be necessary to understand the role of the While the younger LTR7/HERVH element defining the T113.3 gene does not function as an enhancer for XACT, we identified another LTR-derived fragment that takes on this role.
This enhancer belongs to the LTR48B subfamily, a more ancient group of ERV1 retroelements that is found across mammalian species 11 . The XACT/T113.3 enhancer was inserted more than 40 Myr ago and is found across all primate species, where it shows features of an active enhancer, even in species in which XACT and T113.3 are not present, such as rhesus macaque. Importantly, this element seems to have evolved independently from the core of the LTR48B subfamily and has the ability to act as a binding platform for pluripotency transcription factors, such as OCT4, SOX2 and NANOG.
This appears to be a very rare event, as only thirty-four insertions among the one thousand and twenty-six present in the human genome are bound by at least one of these TFs. This suggests that the binding sites were either lost in the core of the LTR48B subfamily or, more likely, acquired in a subset of LTR48B elements. It would be interesting to explore this subset of LTR48B elements and test their influence on the transcriptional status of surrounding genes in pluripotent contexts.
Our analysis thus suggests that an ancestral LTR48B was inserted in the primate lineage and acquired enhancer activity in pluripotent cells. This enhancer likely recruited genes in spatial proximity under its transcriptional control, wiring these genes into the pluripotency network. In the hominoid lineage, the ERV insertions that gave rise to the XACT and T113.3 genes hijacked the LTR48B ancestral enhancer. This raises the question as to whether this LTR-derived enhancer influences the expression of neighboring genes in species where XACT and T113.3 are not present. Indeed, in rhesus macaque iPSCs, the protein-coding gene HTR2C is expressed at higher levels than its hominoid orthologues ( Fig. Sup. 1A) . This suggests that the LTR48B enhancer could regulate the expression of the HTR2C gene in non-hominoid primates and that the appearance of the XACT and Although the function of XACT has yet to be determined, it is tempting to speculate that the coupling of XACT expression to the pluripotent context, mediated by the LTR48B enhancer, could provide a mechanistic link between XCI and developmental timing. On a more general perspective, probing for TE-driven changes in conserved lncRNAs, such as XIST, or novel hominoid-specific lncRNAs, such as XACT, will allow a better understanding of the evolution of the XCI mechanism and what role TEs had in maintaining an essential function, while making it evolutionarily plastic.
Data and materials availability:
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Material and Methods
Cell culture
Experiments on hESCs have been approved by the Agence de la Biomedecine and Transfected cells were harvested 72 h after transfection.
RNA-FISH on hESCs
Cells grown on 12 mm matrigel-coated coverslips (Corning) were fixed 24 to 48 h later in a 4% paraformaldehyde/PBS solution (Electron Microscopy Science) for 12 min at room temperature. Cells were then permeabilized for8 5 min in ice-cold cytoskeletal buffer (NaCl 100 mM, sucrose 300 mM, MgCl 2 3 mM, PIPES 10 mM) supplemented with 0,5% Triton, 1 mM EGTA and 2 mM Vanadyl Ribonucleoside complex (VRC, New England Biolabs), washed three times with 70% ice-cold ethanol and kept at -20°C. Fluorescent probes were obtained by nick-translation, with either spectrum-green or spectrum-orange dUTPs (Abbott Molecular), as previously described 32 For hybridization, approximately 100 ng of labelled probes (enough for three 12 mm coverslips) were precipitated with 10 µg of sheared salmon sperm DNA (ThermoFisher Scientific) and 5 µg of human Cot-1 DNA (ThermoFisher Scientific) and then denatured in deionized formamide (Merck, Sigma-Aldrich) for 7 min at 75°C. Denatured probes were then competed with the human Cot-1 DNA by incubating 30 min at 37°C. Coverslips were dehydrated in sequential washes of 80%, 90% and 100% ethanol just prior to overnight incubation with the probes at 37°C in 50% formamide / 50% hybridization buffer (4X SSC, 20% dextran sulfate, 2 mg/ml BSA, and 2 mM VRC). After three 50% formadehyde / 2X SSC washes and three 2X SSC washes at 42°C for 5 min, coverslips were mounted in Vectashield containing DAPI (Vector Laboratories).
Microscopy and image analysis
All images were acquired with a fluorescence DMI-6000 inverted microscope with a motorized stage (Leica) using a HCX PL APO 100X oil objective, and a CCD Camera 
RNA extraction and RT-qPCR
Total RNAs were extracted from cells using TRIzol (ThermoFisher Scientific) and treated using the DNA free kit (ThermoFisher Scientific) for 1 hour at 37° to remove genomic DNA contamination. 500ng of total RNAs were reverse-transcribed using SuperScript IV reverse transcriptase (ThermoFischer Scientific) and random primers (Promega). cDNA levels were measured using real-time quantitative PCR with the Power SYBR Green PCR master mix (ThermoFisher Scientific) on a ViiA-7 real-time thermal cycler (Applied Biosystems). All samples were analysed in technical duplicates. Normalization was performed using the reference gene GAPDH following the ΔCT or the ΔΔCT method. All the RT-qPCR primers used in this study are listed in Table S1 .
CRISPR/Cas9 deletions
sgRNA sequences flanking each target region were obtained using the web-based tool CRISPOR (http://crispor.tefor.net/) and can be found in Table S1 . For each targeted region, upstream and downstream sgRNAs were cloned under an U6 promoter into the pSpCas9(BB)-2A-GFP (Addgene #48138) and the pSpCas9(BB)-2A-mCherry (generated in house, by replacing the GFP with a mCherry reporter using the NEBuilding HiFi DNA Assembly Cloning Kit [New England Biolabs]). All sgRNAs sequences can be found in table S1.
Using the Amaxa 4D-NucleofectorTM system (Lonza), 1x10 6 H1 hESCs were transfected with 2.5 µg of both plasmids (to a total of 5 µg). Cells were sorted by FACS (INFLUX 500-BD BioSciences) 48 h after transfection. 100, 200 or 400 double-positive cells (GFP+ / mCherry+) were plated into a matrigel or laminin-coated 6 cm petri dish in mTeSR supplemented with 1X CloneR (Stemcell technologies). Individual colonies were manually picked into 96 wells approximately 10 days after transfection. Deletions and inversions events were screened by PCR (primers can be found in table S1).
CRISPR interference, lentiviral production and cell infection
sgRNAs targeting either XACT or T113.3 promoters were designed using the web-based tool CRISPOR (http://crispor.tefor.net/) and cloned into the pLKO5.sgRNA.EFS.tGFP vector (Addgene #57823). Sequences can be found in Table S1 . For CRISPR-interference, one million H1 hESCs were infected in suspension with lentiviral particles containing the dCas9-mCherry-KRAB and single sgRNA constructs (MOI of 10), and sorted by FACS (INFLUX 500-BD BioSciences) every week for two to three weeks, to enrich for GFP and mCherry expressing cells (co-expressing dCas9-mCherry-KRAB and sgRNAs). Cells infected with a lentiviral particle containing an empty sgRNA-expressing vector were used as control.
Chromatin immunoprecipitation
ChIP experiments were performed in H1 hESCs stably expressing the CRISPRi constructs, as previously described 52 . Briefly, cells were crosslinked with 1% formaldehyde for 10 min, then quenched with 0.125 mM glycine for 5 min. Cells were then incubated 30 min in swelling buffer (5 mM PIPES pH8, 85 mM KCl, 0.5% NP-40). EDTA; 0.1% SDS; 1% Triton X-100; 500 mM NaCl), washing buffer (10 mM Tris-HCl pH8; 1 mM EDTA; 250 mM LiCl; 0.5% NP-40; 0.5% Na-deoxycholate) and finally twice in TE buffer. Elution from the beads was done in TE/1% SDS. Samples were then reversecrosslinked at 65°C overnight. DNA was finally purified with phenol-chloroform and resuspended in water. The samples were analysed by qPCR. Primer list used can be found in table S1. List of antibodies used in this study can be found in table S1.
Protein extraction and western blot
Total proteins were extracted using RIPA buffer (50 mM Tris-HCl pH8, 1 mM EDTA, 0.5 mM EGTA, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 150 mM NaCl, 
XACT/T113.3 sequence conservation and synteny
XACT and T113.3 sequences were selected from the hg38 human genome assembly for comparison with orthologous sequences from various primate species. These orthologous sequences were identified using BLASTN 53 and confirmed with liftOver 54 on panTro5 (chimpanzee), gorGor4 (gorilla), nomLeu3 (gibbon), rheMac8 (rhesus macaque) and calJac3 (marmoset) genome assemblies. Synteny conservation for XACT, T113.3 and neighbouring protein coding genes (LHFPL1, AMOT, HTR2C and LRCH2) was analysed for the above sequences.
Sequence identities between hg38 and other primates was determined using the MAFFT multiple alignment tool 55 with default parameters. Each primate sequence was independently aligned to hg38 orthologous sequence (using the above mentioned genome assemblies, with the exception of gorilla, in which we used gorGor5). Identity was calculated counting the number of nucleotide matches divided by multiple sequence alignment length. Due to incomplete assemblies of multiple primate species, nucleotides annotated as "N" and neighbouring sequencing gaps were discarded and not considered for identity calculation. For the protein coding genes, only the exons were taken into account to calculate the sequence conservation.
Pluripotency factor binding sites analysis
To detect pluripotency transcription factors binding regions, Rsat matrix-scan 56 was performed using the XACT/T113.3 enhancer hg38 sequences and the following Position Specific Scoring Matrices (PSSM): the transfac M01307 for OCT4, M01123 for NANOG and the jaspar MA0142.1 for SOX2. The most probable sequences (lowest p-values) were then selected as putative binding sites. The same method was used for each primate enhancer sequences. P-values were calculated using Rsat matrix-scan tool.
LTR48B human consensus sequences and logo were extracted from the Dfam website 57 .
A multiple alignment with MAFFT was performed to compare the XACT/T113.3 enhancer sequence with the LTR48B consensus sequence. P-values were calculated as described above. In parallel, a Hiden Markov Model (hmm) file was extracted from Dfam website. This file was converted to a PSSM using hmmlogo from hmmer tool (hmmer.org). From this matrix, the sequences corresponding to the identified binding sites in the XACT/T113.3 enhancer were selected. Consensus and reference matrices were compared using RSAT compare-matrices.
For ChIP-seq analysis, OCT4 and NANOG binding profiles on LTR48B and LTR7 were analysed using available ChIP-seq datasets: SRR6177948 for OCT4, SRR6177944 for NANOG and SRR6177932 for IgG 43 . LTR7 and LTR48B sequences in the human genome were selected using the RepeatMasker database 58 . ChIP-seq reads were aligned with hg38 using bowtie2 aligner 59 using the following parameters: "bowtie2 -p <threads> --endto-end --no-mixed --no-discordant --minins 100 --maxins 1000 -x hg38". This assigns reads with multiple hits of similar mapping quality to one of those locations randomly. In order to select only uniquely mapped reads, we used a previously reported custom script 60 . SAM files were sorted, compressed and indexed using samtools sort and samtools index 61 . PCR duplicates were then removed using MarkDuplicates from the Picard tool (http://broadinstitute.github.io/picard/). bigWigs were obtained with bamCompare from deepTools 62 , which calculates the log2 ratio between the ChIP-seq and a ChIP-seq IgG control. A matrix for the relative-coverage of reads in the bigWig was then calculated for all the LTRs belonging to the LTR48B and LTR7 subfamilies using computeMatrix (deepTools). This matrix was finally plotted as a heatmap with plotHeatmap or as a binding profile around subfamilies of LTRs with plotProfile (deepTools).
In order to calculate the number of uniquely mapped reads aligning to different classes of LTRs, we calculated the number of reads that aligned to each individual LTR using samtools bedcov. For each individual LTR, a RPKM value was calculated. A control set of sequences was extracted taking one thousand random sequences from hg38 of a length of 390nt (average length of LTR48B and LTR7 elements in the genome). ggplot2 and ggpubr 63 were used to create boxplots and determine statistical values (t-test). Peak calling was performed with MACS2 with default parameters, using IgG ChIP-seq as a control sample. In order to calculate the number of peaks on LTR7 and LTR48B, we used bedtools intersect to cross the LTRs in the genome to the called peaks. T p = 1.1e-4 p = 1.3e-4 p = 1.2e-4 p = 9.6e-5 p = 6.7e-5 p = 9.5e-5 p = 6.4e-5 p = 3.6e-5 p = 1.1e-5 p = 2.6e-5 p = 4.5e-5 p = 8.8e-6
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A C A T T A T C T T G C G G G p = 2.0e-4 p = 1.0e-4 Publicly available data was obtained from the ENCODE project 64 and CISTROME DB 40 .
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Called peaks for CTCF, OCT4, SOX2 and NANOG are shown as black rectangles. 
